Low vs. high antioxidant dose for COPD flare-ups
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares a low dose versus a high dose of an antioxidant called alpha-lipoic acid, given along with standard care, to see which better reduces inflammation and helps recovery during a COPD flare-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD and have had at least two bad flare-ups each year for the past two years.
- You are now having an acute flare-up (worsening shortness of breath, cough, or phlegm) that started within the last 14 days.
- You do not have asthma, pneumonia, tuberculosis, or other serious lung diseases.
- You are not allergic to alpha-lipoic acid, and you do not have severe liver, kidney, or heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses two simple blood tests (MxA and CRP) to help doctors decide whether you need antibiotics for a COPD flare-up. It aims to use medicines more wisely and avoid unnecessary side effects.
This trial tests a medicine called alpha-1 antitrypsin given through an IV to people hospitalized with a serious COPD exacerbation. The goal is to see if it helps them recover faster.
This trial tests whether vitamin C supplements can improve health in people with COPD. It aims to see if the antioxidant effects of vitamin C help manage the disease and slow its progression.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
This study uses a simple blood test to help doctors decide if people having a COPD flare-up need antibiotics or steroids. It may help you get the right treatment faster and avoid unnecessary medications.
This trial tests whether a targeted supplement (vitamins D and fatty acids) can help people with COPD. It’s meant for people who are medically stable and not currently dealing with a recent COPD flare-up.
Hear when a new Acute Exacerbation Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.